Dimasi Catherine G, Darby Jack R T, Holman Stacey L, Quinn Megan, Meakin Ashley S, Seed Mike, Wiese Michael D, Morrison Janna L
Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.
Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
J Mol Cell Cardiol Plus. 2024 Jul 18;9:100084. doi: 10.1016/j.jmccpl.2024.100084. eCollection 2024 Sep.
The adult mammalian heart is unable to undergo cardiac repair, limiting potential treatment options after cardiac damage. However, the fetal heart is capable of cardiac repair. In preparation for birth, cardiomyocytes (CMs) undergo major maturational changes that include exit from the cell cycle, hypertrophic growth, and mitochondrial maturation. The timing and regulation of such events in large mammals is not fully understood. In the present study, we aimed to assess this critical CM transition period using pigs as a preclinically relevant model. Left ventricular myocardium from Large White cross Landrace gilts was collected at 91, 98, 106 and 111-113 days gestation (d GA; term = 115d GA) and in piglets at 0-1, 4-5, 14-18, 19-20 days after birth. We found that miR-133a, which has known roles in CM proliferation, was significantly downregulated before birth, before rising postnatally. Likewise, gene expression of and was repressed until birth with a rise postnatally, suggesting a decline in proliferation during late gestation followed by the onset of multinucleation in postnatal life. The timing of the switch in myocardial metabolism was unclear; however, complexes within the electron transport chain and mitochondrial biogenesis followed a similar pattern of decreasing abundance during late gestation and then a rise postnatally. These data suggest that CM maturation events such as cell cycle arrest and mitochondrial maturation occur around birth. These results may prove important to consider for preclinical applications such as the development of new therapeutics for cardiac repair.
成年哺乳动物的心脏无法进行心脏修复,这限制了心脏受损后的潜在治疗选择。然而,胎儿心脏能够进行心脏修复。为了准备出生,心肌细胞(CMs)会经历重大的成熟变化,包括退出细胞周期、肥大生长和线粒体成熟。大型哺乳动物中这些事件的时间和调控尚未完全了解。在本研究中,我们旨在以猪作为临床前相关模型来评估这个关键的CM转变期。在妊娠91、98、106和111 - 113天(d GA;足月 = 115 d GA)收集大白猪与长白猪杂交母猪的左心室心肌,并在出生后0 - 1、4 - 5、14 - 18、19 - 20天收集仔猪的左心室心肌。我们发现,已知在CM增殖中起作用的miR - 133a在出生前显著下调,出生后上升。同样, 和 的基因表达在出生前受到抑制,出生后上升,这表明在妊娠后期增殖下降,随后在出生后多核化开始。心肌代谢转换的时间尚不清楚;然而,电子传递链中的复合物和线粒体生物发生遵循类似的模式,即在妊娠后期丰度下降,然后在出生后上升。这些数据表明,CM成熟事件如细胞周期停滞和线粒体成熟发生在出生前后。这些结果对于临床前应用(如开发心脏修复新疗法)可能具有重要意义。